Aposense

Molecular imaging and drug development based on apoptosis-based technology

placePetah Tikva, Central District, Israel calendar_todayFounded 1996 groups12 employees language aposense.com

Innovation

31 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 588 times.

YearFilings
20154
20164
20177
20186
20196
20205
20213
20225
20232
20246
20253
20261

Investor mix

7 investors on record; lead investors include MediTech Partners, Clal Biotechnology Industries, Pontifax, Docor.

Investor typeCountShare
Venture capital571%
Private equity114%
Bank & private debt114%
Coming soon